| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 106.658 | 101.141 | 124.898 | 1.022.607 | 405.798 | 254.942 | - | - |
| Total Income - EUR | - | - | 107.718 | 101.144 | 125.528 | 1.022.702 | 405.810 | 261.913 | - | - |
| Total Expenses - EUR | - | - | 91.091 | 96.475 | 105.765 | 785.216 | 280.644 | 221.984 | - | - |
| Gross Profit/Loss - EUR | - | - | 16.627 | 4.669 | 19.763 | 237.486 | 125.166 | 39.929 | - | - |
| Net Profit/Loss - EUR | - | - | 15.550 | 3.634 | 18.503 | 225.698 | 107.543 | 27.094 | - | - |
| Employees | - | - | 1 | 1 | 2 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Four Mer Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 13 | 0 | 0 | 0 | 12.118 | 8.230 | - | - |
| Current Assets | - | - | 34.491 | 63.422 | 81.987 | 364.922 | 412.585 | 224.671 | - | - |
| Inventories | - | - | 4.703 | 13.455 | 38.451 | 128.767 | 58.678 | 2.347 | - | - |
| Receivables | - | - | 22.880 | 38.031 | 22.427 | 184.492 | 212.963 | 127.294 | - | - |
| Cash | - | - | 6.909 | 11.935 | 21.109 | 51.663 | 140.944 | 95.030 | - | - |
| Shareholders Funds | - | - | 15.501 | 18.850 | 36.988 | 225.839 | 328.373 | 185.085 | - | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | - | 19.019 | 44.572 | 45.112 | 139.255 | 96.450 | 48.100 | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Four Mer Pharma Srl